Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Generally healthy~* Postmenopausal~* Hysterectomized or non-hysterectomized~* Moderate or severe vaginal dryness and soreness~Exclusion Criteria:~* Known, suspected, or past history of breast cancer~* Known, suspected, or past history of hormone-dependent tumor~* Genital bleeding of unknown etiology~* Acute thrombophlebitis or thromboembolic disorders or a past history of these conditions, associated with previous estrogen use~* Vaginal infection~* Use of exogenous corticosteroids or sex hormones within 8 weeks of starting active treatment in study~* Use of vaginal, oral or vulvar homeopathic preparations within seven days of starting active treatment in study~* History of treatment with diethylstilbestrol

- Gender: FEMALE
- Minimum Age: 45 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).